期刊文献+

宫颈癌介入下新辅助联合化疗毒性反应及并发症处理的临床体会 被引量:1

Management of Toxicity and Complications of Interventional Chemotherapy in Cervical Cancer
下载PDF
导出
摘要 目的:探讨介入化疗栓塞加放疗治疗中晚期宫颈癌的近期化疗毒性反应及并发症的预防及处理。方法:对8例中晚期宫颈癌患者采用介入超选择动脉插管化疗及栓塞,术后配合手术或放射治疗。结果:化疗反应及并发症,最常见的为消化道反应和骨髓抑制,本组8例均出现。其次为肝功能异常,梗阻性肾病,栓塞综合征等,对症治疗后都能恢复,无1例发生化疗相关死亡。结论:①严格术前介入治疗的适应证。②动脉插管应在DSA下进行,定位准确。尽量超选择性插管,使药物仅进入靶动脉,在血管有变异时灵活处理,避免损伤非肿瘤血管。③注意对介入治疗的并发症防治,尤其是栓塞综合征。介入化疗栓塞可以有效降低分期,增加了Ⅱ期手术的机会;超选择子宫动脉化疗栓塞对晚期宫颈癌是一种安全有效的治疗措施。 Objective:To study the prevention and management of the toxicity and complications of interventional chemotherapy and embolization with radiotherapy for mataphase and advanced cervical cancer. Methods:8 cases of mataphase and advanced cervical cancer performed interventional chemotherapy and embolization with radiotherapy,partly arterial chemoembolization. Results:The commonest response and complication of chemotherapy was leucopenia and gastrointestinal complication, whih occured in all 8 cases. The second ones was abnormal liver function,obstructive nephropathy and embolism syndrome. All symptoms recovered after symptomatic treatment, and no case dead from chemotherapy. Conclusion: ① The indiction of interventional therapy should be grasped strictly. ②The arterial cannula should be exactly fixed and guided by DSA. The selective cannulation can guide the drug into target artery and prevent normal vessels from injury. ③It should be accentuated to prevent and treat the complications of interventional therapy, specially embolism syndrome. The interventional chemotherapy and embolization can reduce the stage of cancer and increase the opportunity of surgery in stage Ⅱ . It was a safe and effective therapy for advanced cervical cancer.
出处 《内蒙古医学杂志》 2006年第10期904-906,共3页 Inner Mongolia Medical Journal
关键词 宫颈癌 放疗 化疗 毒性反应 并发症 临床体会 Cervical cancer Radiotherapy Chemotherapy
  • 相关文献

参考文献8

  • 1陈春林,梁立治,刘佩鸣,谭道彩,马奔,方艺川,余莉萍,何燕.介入治疗在中晚期妇科恶性肿瘤中应用的临床研究[J].中国实用妇科与产科杂志,2000,16(11):667-669. 被引量:114
  • 2杨秀玉.血管性介入技术在滋养细胞肿瘤诊治中的评价[J].实用妇产科杂志,2005,21(4):201-203. 被引量:8
  • 3黄欧平,张晓玲.妇产科血管性介入治疗的副反应和并发症[J].实用妇产科杂志,2005,21(4):205-207. 被引量:21
  • 4Patt YZ,Hoque A,Lozano R,et al.Phase Ⅱ trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin[J].Jpn Clin Oncol,1997,15(4):1432.
  • 5Kaneyasu Y,Okawa MK,Kokubo N,et al.Clinical evaluation of intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy[J].Gan To Kagaku Ryoho,1997,24(12):1813.
  • 6Uchija K,Akaza H,Hattori K,et al.Antiemetic efficacy of granisetron:a randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy[J].Jpn J Clin Oncol,1999,29(2):87.
  • 7Noguchi M,Murata R,Sagoh T,et al.Intraarterial chemotherapy combined with radiation therapy for advanced cancer of the uterine cervix[J].Gan To Kagaku Ryoho,1998,25(9):1314.
  • 8张国楠.子宫颈癌的术前动脉化疗[J].实用妇产科杂志,2005,21(4):199-201. 被引量:24

二级参考文献3

共引文献159

同被引文献18

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部